- Home
- ATXS vs MEI Comparison
ATXS vs MEI Comparison
Compare ATXS & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- MEI
- Stock Information
- Founded
- ATXS 2008
- MEI 1946
- Country
- ATXS United States
- MEI United States
- Employees
- ATXS N/A
- MEI N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- MEI Electrical Products
- Sector
- ATXS Health Care
- MEI Technology
- Exchange
- ATXS Nasdaq
- MEI Nasdaq
- Market Cap
- ATXS 401.2M
- MEI 464.2M
- IPO Year
- ATXS 2015
- MEI N/A
- Fundamental
- Price
- ATXS $5.34
- MEI $6.38
- Analyst Decision
- ATXS Strong Buy
- MEI Buy
- Analyst Count
- ATXS 5
- MEI 3
- Target Price
- ATXS $26.60
- MEI $11.67
- AVG Volume (30 Days)
- ATXS 276.5K
- MEI 641.0K
- Earning Date
- ATXS 03-11-2025
- MEI 03-05-2025
- Dividend Yield
- ATXS N/A
- MEI 8.74%
- EPS Growth
- ATXS N/A
- MEI N/A
- EPS
- ATXS N/A
- MEI N/A
- Revenue
- ATXS N/A
- MEI $1,068,300,000.00
- Revenue This Year
- ATXS N/A
- MEI N/A
- Revenue Next Year
- ATXS N/A
- MEI $5.40
- P/E Ratio
- ATXS N/A
- MEI N/A
- Revenue Growth
- ATXS N/A
- MEI N/A
- 52 Week Low
- ATXS $5.29
- MEI $5.84
- 52 Week High
- ATXS $14.04
- MEI $17.45
- Technical
- Relative Strength Index (RSI)
- ATXS 28.85
- MEI 30.76
- Support Level
- ATXS $5.89
- MEI $6.56
- Resistance Level
- ATXS $6.52
- MEI $7.02
- Average True Range (ATR)
- ATXS 0.40
- MEI 0.36
- MACD
- ATXS -0.06
- MEI 0.13
- Stochastic Oscillator
- ATXS 2.50
- MEI 35.90
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.